chrX-129540745-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000276.4(OCRL):​c.41C>T​(p.Thr14Ile) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00689 in 1,205,712 control chromosomes in the GnomAD database, including 23 homozygotes. There are 2,616 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T14A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0048 ( 2 hom., 148 hem., cov: 22)
Exomes 𝑓: 0.0071 ( 21 hom. 2468 hem. )

Consequence

OCRL
NM_000276.4 missense, splice_region

Scores

4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 2.14
Variant links:
Genes affected
OCRL (HGNC:8108): (OCRL inositol polyphosphate-5-phosphatase) This gene encodes an inositol polyphosphate 5-phosphatase. This protein is involved in regulating membrane trafficking and is located in numerous subcellular locations including the trans-Golgi network, clathrin-coated vesicles and, endosomes and the plasma membrane. This protein may also play a role in primary cilium formation. Mutations in this gene cause oculocerebrorenal syndrome of Lowe and also Dent disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047611).
BP6
Variant X-129540745-C-T is Benign according to our data. Variant chrX-129540745-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 129850.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-129540745-C-T is described in Lovd as [Likely_benign]. Variant chrX-129540745-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00482 (534/110820) while in subpopulation NFE AF = 0.00746 (393/52690). AF 95% confidence interval is 0.00685. There are 2 homozygotes in GnomAd4. There are 148 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OCRLNM_000276.4 linkc.41C>T p.Thr14Ile missense_variant, splice_region_variant Exon 2 of 24 ENST00000371113.9 NP_000267.2 Q01968-1
OCRLNM_001318784.2 linkc.44C>T p.Thr15Ile missense_variant Exon 2 of 24 NP_001305713.1 Q504W7
OCRLNM_001587.4 linkc.41C>T p.Thr14Ile missense_variant, splice_region_variant Exon 2 of 23 NP_001578.2 Q01968-2A0A2X0TVZ9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OCRLENST00000371113.9 linkc.41C>T p.Thr14Ile missense_variant, splice_region_variant Exon 2 of 24 1 NM_000276.4 ENSP00000360154.4 Q01968-1
OCRLENST00000357121.5 linkc.41C>T p.Thr14Ile missense_variant, splice_region_variant Exon 2 of 23 1 ENSP00000349635.5 Q01968-2

Frequencies

GnomAD3 genomes
AF:
0.00482
AC:
534
AN:
110771
Hom.:
2
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00171
Gnomad ASJ
AF:
0.000760
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00116
Gnomad FIN
AF:
0.0131
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00746
Gnomad OTH
AF:
0.00201
GnomAD2 exomes
AF:
0.00565
AC:
1036
AN:
183264
AF XY:
0.00612
show subpopulations
Gnomad AFR exome
AF:
0.000989
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.00120
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0179
Gnomad NFE exome
AF:
0.00760
Gnomad OTH exome
AF:
0.00575
GnomAD4 exome
AF:
0.00710
AC:
7775
AN:
1094892
Hom.:
21
Cov.:
30
AF XY:
0.00685
AC XY:
2468
AN XY:
360456
show subpopulations
Gnomad4 AFR exome
AF:
0.000722
AC:
19
AN:
26332
Gnomad4 AMR exome
AF:
0.00202
AC:
71
AN:
35200
Gnomad4 ASJ exome
AF:
0.00119
AC:
23
AN:
19368
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
30192
Gnomad4 SAS exome
AF:
0.00174
AC:
94
AN:
54061
Gnomad4 FIN exome
AF:
0.0172
AC:
698
AN:
40518
Gnomad4 NFE exome
AF:
0.00789
AC:
6621
AN:
839140
Gnomad4 Remaining exome
AF:
0.00533
AC:
245
AN:
45985
Heterozygous variant carriers
0
252
504
756
1008
1260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00482
AC:
534
AN:
110820
Hom.:
2
Cov.:
22
AF XY:
0.00448
AC XY:
148
AN XY:
33034
show subpopulations
Gnomad4 AFR
AF:
0.00121
AC:
0.00121105
AN:
0.00121105
Gnomad4 AMR
AF:
0.00170
AC:
0.00170326
AN:
0.00170326
Gnomad4 ASJ
AF:
0.000760
AC:
0.000759878
AN:
0.000759878
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00116
AC:
0.0011592
AN:
0.0011592
Gnomad4 FIN
AF:
0.0131
AC:
0.0131092
AN:
0.0131092
Gnomad4 NFE
AF:
0.00746
AC:
0.00745872
AN:
0.00745872
Gnomad4 OTH
AF:
0.00198
AC:
0.0019802
AN:
0.0019802
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00615
Hom.:
282
Bravo
AF:
0.00396
TwinsUK
AF:
0.00755
AC:
28
ALSPAC
AF:
0.00900
AC:
26
ESP6500AA
AF:
0.000782
AC:
3
ESP6500EA
AF:
0.00535
AC:
36
ExAC
AF:
0.00562
AC:
682
EpiCase
AF:
0.00654
EpiControl
AF:
0.00865

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 19, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:4
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 12, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 11, 2014
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lowe syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephrolithiasis/nephrocalcinosis Benign:1
Jan 16, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.34
T;.
FATHMM_MKL
Benign
0.37
N
LIST_S2
Benign
0.41
T;T
MetaRNN
Benign
0.0048
T;T
MetaSVM
Uncertain
-0.013
T
MutationAssessor
Benign
1.0
L;L
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-0.67
N;N
REVEL
Benign
0.23
Sift
Uncertain
0.018
D;D
Sift4G
Benign
0.34
T;T
Polyphen
0.0
B;B
Vest4
0.15
MVP
0.75
MPC
0.27
ClinPred
0.0052
T
GERP RS
3.7
Varity_R
0.061
gMVP
0.68
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61752970; hg19: chrX-128674722; COSMIC: COSV105254410; COSMIC: COSV105254410; API